Mintz is pleased to share that Member and Co-chair of the firm’s Securities & Capital Markets Practice Megan N. Gates has been named to The Deal’s 2020 Top Women in Dealmaking list in the M&A category. Ms. Gates will be featured in an upcoming issue of The Deal’s “The Dealmaker Quarterly” publication.
Ms. Gates advises public companies on capital-raising transactions, U.S. Securities and Exchange Commission reporting obligations, and mergers and acquisitions. Passionate about the life sciences industry, she has over 25 years of experience in the biotechnology field. In recognition of her professional accomplishments, Ms. Gates was recommended by The Legal 500 United States for Healthcare: Life Sciences and Capital Markets: Equity in 2020. Recognized in the M&A category for Top Women in Dealmaking, Ms. Gates recently advised Biogen in its $890 million sale of a biologics manufacturing facility in Denmark to FujiFilm Corporation, and Spring Bank Pharmaceuticals, Inc. on its share exchange transaction with F-star Therapeutics, among other significant transactions and initial public offerings.
In addition to her role as Co-chair of the Securities & Capital Markets Practice, Ms. Gates is a leader in Mintz’s recently-formed Environmental, Social, and Corporate Governance (ESG) Practice focused on helping clients navigate complex, rapidly-evolving ESG concerns and priorities, such as responsible investing and investor demands for accountability. She also serves on various firm committees, including formerly on the Policy Committee, and mentors women associates. Active in the Boston legal and nonprofit communities, Ms. Gates holds leadership roles and serves on the boards of Pine Street Inn and the Boston Bar Foundation, among other organizations.
Mintz is committed to promoting women attorneys to Member and other influential leadership positions. Ms. Gates is one of many exceptional women at Mintz to serve as industry trailblazers and role models for young associates of all genders and backgrounds.